2-[2-[2-(oxiran-2-yl)ethoxy]ethyl]oxirane (CED0212050)

Record Information

Version

1.0

Creation Date

2026-08-24 15:36:32 UTC

Update Date

2026-08-24 15:36:32 UTC

SynCED ID

CED0212050

Secondary Accession Numbers

CHEM251296

Identification

Common Name

2-[2-[2-(oxiran-2-yl)ethoxy]ethyl]oxirane

Class

Small Molecule

Description

2-[2-[2-(oxiran-2-yl)ethoxy]ethyl]oxirane belongs to the epoxides, a class of organoheterocyclic compounds within the organic compounds. This compound has the formula C8H14O3 and an average molecular weight of 158.19 g/mol.

Contaminant Type

Not Available

Chemical Structure

MOL SDF PDB SMILES InChI

Synonyms

Not Available

Chemical Formula

C₈H₁₄O₃

Average Molecular Mass

158.190 g/mol

Monoisotopic Mass

158.094 g/mol

CAS Registry Number

10580-77-5

IUPAC Name

Not Available

Traditional Name

Not Available

SMILES

Not Available

InChI Identifier

InChI=1S/C8H14O3/c1(7-5-10-7)3-9-4-2-8-6-11-8/h7-8H,1-6H2

InChI Key

CMZHETMDWDVBCX-UHFFFAOYSA-N

Chemical Taxonomy

Classification

Not classified

Biological Properties

Status

Detected and Not Quantified

Origin

Not Available

Cellular Locations

Not Available

Biofluid Locations

Not Available

Tissue Locations

Not Available

Applications

Not Available

Biological Roles

Not Available

Chemical Roles

Not Available

Organoleptic Effects

Not Available

Physical Properties

State

Not Available

Appearance

Not Available

Experimental Properties

Property	Value
Melting Point	Not Available
Boiling Point	Not Available
Solubility	Not Available

Predicted Properties

Not Available

Spectra

Not Available

Toxicity Profile

Toxicity Values

Toxicity Value	Organism	Dose Descriptor	Route of Exposure	Predicted or Experimental	Toxicity Rating	Reference
2287.0 Log mg/kg [1300:4100]	Rat	LD50	oral	predicted	Not Available	Not Available

Toxicity / Toxin Class

Not Available

Mechanism of Toxicity

Not Available

Carcinogenicity (IARC Classification)

Not Available

Minimum Risk Level

Not Available

Symptoms

Not Available

Treatment

Not Available

Health Effects

Health Effect	Relationship	Direction	Reference

Exposure Sources

Source ID	Source	Sector	Reference
CEDs000511	Conductors Or Conductive Bodies Characterised By The Conductive Materials?Conductors, or conductive bodies, are materials that allow the flow of electrical current, typically made from metals such as copper, aluminum, or silver.	Electrical & Electronic Equipment	Not Available
CEDs000561	Perfumes Within Detergents And Soaps?Perfumes within detergents and soaps are synthetic fragrance compounds added to enhance the sensory experience of cleaning products.	Household cleaning & consumer products	Not Available
CEDs000641	Foam Dyeing?Foam dyeing is a textile dyeing technique that utilizes a foaming agent to create a dye solution in a gaseous form, allowing for the application of dyes onto fabrics.	Textiles, leather & furnishings	Not Available
CEDs000696	Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.	Industrial manufacturing & chemical processing	Not Available
CEDs000739	Inks?Inks are complex mixtures composed of pigments or dyes, solvents, resins, and additives used primarily for printing and writing applications.	Paper, pulp & fiber products	Not Available
CEDs000740	Paper?Paper production involves the processing of wood fibers and the use of various chemicals, which can lead to synthetic chemical contamination.	Paper, pulp & fiber products	Not Available

Pathways

0 pathwaysPathway Source: PathBank

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets

Structure	Protein	UniProt ID	Organism	Relationship	Details
Click to view 3D structure	Autotaxin	Q13822	Humans	Predicted (SEA)	Prediction Confidence Score 0.2 Applicability Domain 0.2 Low confidence Statistical Significance 0.0683 Supporting Reference Compounds 40 E-value 531.71
Click to view 3D structure	Lysophosphatidic acid receptor 3	Q8K5E0	Rattus norvegicus	Predicted (SEA)	Prediction Confidence Score 0.197 Applicability Domain 0.2 Low confidence Statistical Significance 0.002 Supporting Reference Compounds 4 E-value 15.5698
Click to view 3D structure	Lysophosphatidic acid receptor 2	Q9HBW0	Humans	Predicted (SEA)	Prediction Confidence Score 0.179 Applicability Domain 0.2 Low confidence Statistical Significance 0.1722 Supporting Reference Compounds 30 E-value 1340.33
Click to view 3D structure	Non-lysosomal glucosylceramidase	Q9HCG7	Humans	Predicted (SEA)	Prediction Confidence Score 0.177 Applicability Domain 0.186 Low confidence Statistical Significance 0.0158 Supporting Reference Compounds 21 E-value 123.157
Click to view 3D structure	Ceramide glucosyltransferase	O88693	Mus musculus	Predicted (SEA)	Prediction Confidence Score 0.177 Applicability Domain 0.186 Low confidence Statistical Significance 0.0123 Supporting Reference Compounds 14 E-value 95.5988
Click to view 3D structure	Muscarinic acetylcholine receptor M4	P08173	Humans	Predicted (SEA)	Prediction Confidence Score 0.17 Applicability Domain 0.258 Low confidence Statistical Significance 0.9058 Supporting Reference Compounds 297 E-value 7051.35
Click to view 3D structure	Muscarinic acetylcholine receptor M2	P08172	Humans	Predicted (SEA)	Prediction Confidence Score 0.166 Applicability Domain 0.258 Low confidence Statistical Significance 0.9574 Supporting Reference Compounds 373 E-value 7453.13
Click to view 3D structure	Sucrase-isomaltase	B5THE3	Mus musculus	Predicted (SEA)	Prediction Confidence Score 0.165 Applicability Domain 0.186 Low confidence Statistical Significance 0.0078 Supporting Reference Compounds 7 E-value 61.1116
Click to view 3D structure	Lysosomal acid glucosylceramidase	P04062	Humans	Predicted (SEA)	Prediction Confidence Score 0.158 Applicability Domain 0.186 Low confidence Statistical Significance 0.2721 Supporting Reference Compounds 35 E-value 2118.04
Click to view 3D structure	Alpha-1A adrenergic receptor	P35348	Humans	Predicted (SEA)	Prediction Confidence Score 0.154 Applicability Domain 0.157 Low confidence Statistical Significance 0.9772 Supporting Reference Compounds 376 E-value 7607.43
Click to view 3D structure	Alpha-1D adrenergic receptor	P25100	Humans	Predicted (SEA)	Prediction Confidence Score 0.154 Applicability Domain 0.157 Low confidence Statistical Significance 0.9649 Supporting Reference Compounds 258 E-value 7511.44
Click to view 3D structure	Alpha-1B adrenergic receptor	P35368	Humans	Predicted (SEA)	Prediction Confidence Score 0.154 Applicability Domain 0.157 Low confidence Statistical Significance 0.9684 Supporting Reference Compounds 298 E-value 7538.92
Click to view 3D structure	Lysosomal alpha-glucosidase	P70699	Mus musculus	Predicted (SEA)	Prediction Confidence Score 0.152 Applicability Domain 0.186 Low confidence Statistical Significance 0.0118 Supporting Reference Compounds 7 E-value 92.1735
Click to view 3D structure	5-hydroxytryptamine receptor 1A	P08908	Humans	Predicted (SEA)	Prediction Confidence Score 0.151 Applicability Domain 0.157 Low confidence Statistical Significance 0.9895 Supporting Reference Compounds 953 E-value 7703.02
Click to view 3D structure	Presenilin-2	P49810	Humans	Predicted (SEA)	Prediction Confidence Score 0.148 Applicability Domain 0.148 Low confidence Statistical Significance 0.0526 Supporting Reference Compounds 1 E-value 409.643
Click to view 3D structure	5-hydroxytryptamine receptor 1A	P19327	Rattus norvegicus	Predicted (SEA)	Prediction Confidence Score 0.145 Applicability Domain 0.157 Low confidence Statistical Significance 0.986 Supporting Reference Compounds 541 E-value 7676.09
Click to view 3D structure	Lysosomal alpha-glucosidase	P10253	Humans	Predicted (SEA)	Prediction Confidence Score 0.144 Applicability Domain 0.152 Low confidence Statistical Significance 0.0451 Supporting Reference Compounds 21 E-value 351.022
Click to view 3D structure	Maltase-glucoamylase	O43451	Humans	Predicted (SEA)	Prediction Confidence Score 0.142 Applicability Domain 0.152 Low confidence Statistical Significance 0.2174 Supporting Reference Compounds 30 E-value 1692.13
Click to view 3D structure	Alpha-1D adrenergic receptor	P23944	Rattus norvegicus	Predicted (SEA)	Prediction Confidence Score 0.141 Applicability Domain 0.157 Low confidence Statistical Significance 0.9445 Supporting Reference Compounds 105 E-value 7353.01
Click to view 3D structure	Sucrase-isomaltase, intestinal	P23739	Rattus norvegicus	Predicted (SEA)	Prediction Confidence Score 0.139 Applicability Domain 0.152 Low confidence Statistical Significance 0.0242 Supporting Reference Compounds 25 E-value 188.551
Click to view 3D structure	D(4) dopamine receptor	P21917	Humans	Predicted (SEA)	Prediction Confidence Score 0.137 Applicability Domain 0.149 Low confidence Statistical Significance 0.993 Supporting Reference Compounds 524 E-value 7730.82
Click to view 3D structure	Sucrase-isomaltase, intestinal	P14410	Humans	Predicted (SEA)	Prediction Confidence Score 0.136 Applicability Domain 0.143 Low confidence Statistical Significance 0.0578 Supporting Reference Compounds 14 E-value 450.28
Click to view 3D structure	Ceramide glucosyltransferase	Q16739	Humans	Predicted (SEA)	Prediction Confidence Score 0.136 Applicability Domain 0.14 Low confidence Statistical Significance 0.7448 Supporting Reference Compounds 20 E-value 5798.6
Click to view 3D structure	High affinity choline transporter 1	Q9GZV3	Humans	Predicted (SEA)	Prediction Confidence Score 0.135 Applicability Domain 0.258 Low confidence Statistical Significance 0.962 Supporting Reference Compounds 75 E-value 7489.25
Click to view 3D structure	Lysophosphatidic acid receptor 1	P61794	Rattus norvegicus	Predicted (SEA)	Prediction Confidence Score 0.135 Applicability Domain 0.2 Low confidence Statistical Significance 0.0843 Supporting Reference Compounds 6 E-value 656.269